Home | Services | Building Value | Clients | Management | News | Community

Press Releases

July 2, 2008
July 1, 2008
May 27, 2008
May 7, 2008
April 17, 2008
April 15a, 2008
April 15, 2008
March 10, 2008
December 13, 2007
November 29, 2007
November 15, 2007
November 13, 2007
October 31, 2007
October 26, 2007
October 16, 2007
September 17, 2007
August 6, 2007
July 27, 2007
July 23,2007
May 29, 2007
May 21, 2007a
May 21, 2007
May 15, 2007
April 9, 2007
February 20, 2007
February 7, 2007
January 2, 2007
November 29, 2006
August 7, 2006
May 1, 2006
January 25, 2006
December 12, 2005
October 3, 2005
July 20, 2005
March 18, 2005

 

            

DayStar Announces $63.8 Million Public Offering

 

HALFMOON, N.Y., Oct. 26 /PRNewswire-FirstCall/ -- DayStar Technologies, Inc. (Nasdaq: DSTI) announced today the pricing of an underwritten public offering of 15,000,000 shares of common stock, all of which are being sold by the company at $4.25 per share before underwriting discounts and commissions. DayStar has granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares to cover any over-allotments.

 

DayStar plans to use the net proceeds from the offering for the repayment in full of $9.2 million of existing indebtedness for borrowed funds and to engineer to-scale and manufacture the company's proprietary deposition tool. The company intends to use the remaining net proceeds from the offering for the construction of a 25MW manufacturing line, working capital and other general corporate purposes.

 

ThinkEquity Partners LLC acted as bookrunning lead manager for the offering with Broadpoint Capital, Inc. acting as co-manager.

 

A registration statement relating to these securities has been filedand declared effective by the Securities and Exchange Commission and is available on the Securities and Exchange Commission's website at http://www.sec.gov. A final prospectus relating to this offering may be obtained from ThinkEquity Partners LLC, 600 Montgomery Street, 8th Floor, San Francisco, CA 94111 or prospectus@thinkequity.com, or from Broadpoint Capital, Inc., One Penn Plaza, 42nd Floor, New York, NY 10119 or equity.syndicate@broadpointsecurities.com.

 

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, any of the securities, nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State. Any offer will be made only by means of a prospectus included in the registration statement.

 

About DayStar Technologies, Inc.

 

DayStar Technologies, Inc. is engaged in the development, manufacturing, and marketing of photovoltaic products based upon CIGS thin film semiconductor technology.

 

This news release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including risks that we will not be able to manufacture our products or that they will not perform as expected, and other risks identified in our registration statement on Form SB-2 and other filings with the SEC. You should consider these factors in evaluating the forward- looking statements included herein, and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof and DayStar Technologies, Inc. undertakes no obligation to update such statements.

 

About InfusionCapital:

 

InfusionCapital (www.infusioncapital.com), an investment banking consultancy firm located in Celebration, Florida, specializes in a unique, integrated approach to corporate governance and capital formation.  The firm has extensive experience in assisting client companies with each phase of capitalization and the complex processes that accompany it. 

 

For more information, contact:

 

Kellie Caughorn

InfusionCapital

407-566-1051

kcaughorn@InfusionCapital.com

www.infusioncapital.com  

 

 

 

© 2007 InfusionCapital. All Rights Reserved